CAY10784

CAY10784 Suppliers list
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Products Intro: Product Name:STAT3-IN-17
CAS:1245814-52-1
Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Email: 486064515@qq.com
Products Intro: Product Name:STAT3-IN-17
CAS:1245814-52-1
Purity:98% Package:500mg;1g;5g
Company Name: ChemeGen 中国  
Tel: 18818260767
Email: sales@chemegen.com
Products Intro: Product Name:CAY10784
CAS:1245814-52-1
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Email: 3007606172@qq.com
Products Intro: Product Name:CAY10784
CAS:1245814-52-1
Purity:>98% Package:mg
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Email: marketing@tsbiochem.com
Products Intro: Product Name:CAY10784;CAY10784,CAY-10784
CAS:1245814-52-1
Purity:98% Package:25 mg
CAY10784 Basic information
Product Name:CAY10784
Synonyms:CAY10784;CAY10784,CAY-10784;Benzamide, N-(5-nitro-2-thiazolyl)-4-(trifluoromethyl)-;N-(5-nitro-2-thiazolyl)-4-(trifluoromethyl)-benzamide;STAT3-IN-17
CAS:1245814-52-1
MF:C11H6F3N3O3S
MW:317.24
EINECS:
Product Categories:
Mol File:1245814-52-1.mol
CAY10784 Structure
CAY10784 Chemical Properties
density 1.615±0.06 g/cm3(Predicted)
storage temp. -20°C
solubility DMF: 30 mg/ml,DMF:PBS (pH 7.2) (1:2): 0.33 mg/ml,DMSO: 10 mg/ml,Ethanol: 1 mg/ml
form A crystalline solid
pka5.82±0.50(Predicted)
color Light yellow to yellow
Safety Information
MSDS Information
CAY10784 Usage And Synthesis
Biological ActivityCAY10784 is a STAT3 inhibitor (IC50 = 0.74 μM in a reporter assay) and a derivative of WP1066 .1 It inhibits proliferation of HeLa, Caco-2, A549, A375, U87MG, and HL-60 cancer cells (IC50s = 1.8, 1.8, 3, 2.8, 2.3, and 1.2 μM, respectively) but not PC3 or HT-29 cancer cells (IC50s = >10 μM for both). CAY10784 is also active against H. pylori and C. jejuni (MICs = 1.6 and 4.7 μM, respectively).2
References1.Lü, Z., Li, X., Li, K., et al.Structure-activity study of nitazoxanide derivatives as novel STAT3 pathway inhibitorsACS Med. Chem. Lett.(2021) 2.Ballard, T.E., Wang, X., Olekhnovich, I., et al.Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: Identification of selective and broad spectrum activityChemMedChem6(2)362-377(2011)
CAY10784 Preparation Products And Raw materials
Tag:CAY10784(1245814-52-1) Related Product Information